From: Effects of a combination treatment of KD5040 and L-dopa in a mouse model of Parkinson’s disease
No. | Compound Name | RT (min) | Area |
---|---|---|---|
1 | 2-Furanmethanol | 4.942 | 57,080 |
2 | Ethanamine | 5.291 | 157,960 |
3 | 1-Butanol, 2-amino-3-methyl | 5.445 | 148,390 |
4 | 4H–Pyran-4-one, 2,3-dihydro-3,5-dihydroxy-6-methyl | 9.576 | 121,071 |
5 | Benzoic acid | 9.875 | 816,509 |
6 | 5-Hydroxymethylfurfural | 10.779 | 476,687 |
7 | Eugenol | 12.695 | 122,008 |
8 | 1,2,3-Benzenetriol | 12.905 | 490,529 |
9 | Adenosine, N6-phenylacetic acid | 13.724 | 1,065,891 |
10 | Quinic acid | 15.801 | 213,470 |
11 | Hexadecanoic acid | 24.38 | 22,373 |
12 | 13-Docosenamide | 26.419 | 851,211 |